HAMDEN, Conn., and BOULDER, Colo., August 25, 2011 – RxGen, a specialty preclinical contract research organization, and miRagen Therapeutics, Inc., a preclinical-stage biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the award of a Small Business Innovation Research (SBIR) grant by the National ...
Therapeutic Development Through Innovative Research
Monthly Archives: August 2011
